S. Korea’s Celltrion expects limited impact from US executive order on price reduction
Seoul, May 21 (IANS) Celltrion, a leading South Korean biopharmaceutical company, on Wednesday said it expects limited impact from recent US policy developments stemming from a drug pricing executive order… Continue reading S. Korea’s Celltrion expects limited impact from US executive order on price reduction







